Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody - RSC Advances (RSC Publishing)
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma | Blood Cancer Journal
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
A Brief Introduction to PD-1 Antibodies and Immunotherapy | ProSci Incorporated
Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy | Science Advances
Each blocking antibody for PD-1, PD-L1, or PD-L2 requires its own... | Download Scientific Diagram
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis - ScienceDirect
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Identifying New Anti-PD-1 Monoclonal Antibody Drug Candidates
Human PD-1 Antibody MAB10868-100: R&D Systems
Advertorial: Novel Bioassay to Assess PD-1/PD-L1 Therapeutic Antibodies in Development for Immunotherapy
PD1 Antibody Selection Tool | Bio X Cell
PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell - FineTest ELISA Kit | FineTest Antibody | Wuhan Fine Biotech Co., Ltd.
JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
Development of domain-specific PD-L1 antibodies a-b, To assess PD-L1... | Download Scientific Diagram
Cancer: anti-PD-1 / PD-L1 antibodies, new solutions for immunotherapy
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | NEJM
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors | Journal for ImmunoTherapy of Cancer | Full Text
